Anixa Biosciences Company
Anixa Biosciences develops and acquires patented technologies for the purposes of patent monetization and patent assertion.
Technology:
CAR-T, CAR-T therapy, TCR therapy
Industry:
CAR-T, Public
Headquarters:
Melville, New York, United States
Founded Date:
1982-01-01
Employees Number:
1-10
Funding Status:
IPO
Investors Number:
1
Total Funding:
34265000
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-05-26
Last Funding Type:
Grant
Register and Claim Ownership